HSIF14 · House Subcommittee

Health Subcommittee

House Energy and Commerce Subcommittee on Health

Showing the 115th Congress (2017–2018). Back to the 119th Congress

780 bills referred in the 115th Congress

10,366 across the 13 Congresses on file, most in the 117th at 1,379. A referral is not a hearing: most bills sent to a committee are never taken up.

Bills referred, by Congress 107th to 119th

Members
34

Served in the 115th Congress

Meetings
50

Hearings and business meetings in the 115th Congress

Members, 115th Congress 34

Everyone listed on the subcommittee in the 115th Congress, from printed hearings, the Congressional Directory and the official rosters.

Record

Bills, meetings, hearings, reports and more, newest first. In the 115th Congress.

Hearings, markups and business meetings, newest first. In the 115th Congress.

KindSubjectStatusDate
MeetingPersonal Stories from the Opioid CrisisRayburn House Office Building 2123
10 witnesses
  • Ms. Devon Hott, Director of Operations, Recovery Care Partner
  • Ms. Aimee Manzoni D'Arpino, Massachusetts State Chair, Addiction Policy Forum
  • Ms. Lisa Daniels, Co-Founder, Jamie Daniels Foundation
  • Ms. Gail Smith, Substance Use Navigator, Prevention Plus of Burlington County
  • Ms. Kristen Arant, Peer Support Specialist, Kentucky
  • Ms. Paula Peterson, Founding Member, Families Anonymous - Oregon Chapter
  • Ms. Kathy O'Keefe, Executive Director, Winning the Fight
  • Mr. Gary Mendell, Founder and CEO, Shatterproof
  • Ms. Mary Winnefeld, Founder, Stop the Addiction Fatality Epidemic
  • Mr. Michael Gray, CEO and Co-Founder, Actus Analytical
ScheduledApr 19, 2018
HearingCombating the Opioid Crisis: Improving the Ability of Medicare and Medicaid to Provide Care for PatientsRayburn House Office Building 2123
6 witnesses
  • Ms. Kimberly Brandt, Principal Deputy Administrator for Operations, Centers for Medicare and Medicaid Services
  • Mr. Toby Douglas, Senior Vice President for Medicaid Solutions, Centene Corporation
  • The Honorable Michael Botticelli, Executive Director, Grayken Center for Addiction, Boston Medical Center
  • Mr. David Guth, CEO, Centerstone America
  • Mr. John Kravitz, CIO, Geisinger Health System
  • Mr. Sam Srivastava, CEO, Magellan Healthcare
ScheduledApr 11, 2018
HearingCombating the Opioid Crisis: Prevention and Public Health SolutionsRayburn House Office Building 2123
19 witnesses
  • The Honorable Scott Gottlieb,, Commissioner, Food and Drug Administration (FDA)
  • Dr. Anne Schuchat, Acting Director, Centers for Disease Control and Prevention
  • Dr. Christopher Jones,, Director of the National Mental Health and Substance Use Policy Laboratory, Substance Abuse and Mental Health Services Administration
  • Ms. Sue Thau, Public Policy Consultant, Community Anti-Drug Coalitions of America
  • Ms. Cartier Esham, Executive Vice President, Emerging Companies, Biotechnology Innovation Organization
  • Mr. Jeffrey Francer, Senior Vice President and General Counsel, Association for Accessible Medicines
  • Dr. John Holaday, Chairman and CEO, DisposeRx
  • The Honorable Patrick Kennedy, Founder, The Kennedy Forum
  • Dr. Eric Strain, Director of the Center for Substance Abuse Treatment and Research, Johns Hopkins University School of Medicine
  • Dr. Kenneth Martz, Special Projects Consultant, Gaudenzia
  • Mr. Brad Bauer, Senior Vice President, Appriss Health
  • Dr. William Banner, Board President, American Association of Poison Control Centers
  • Dr. Michael Kilkenny, Physician Director, Cabell-Huntington Health Department of West Virginia
  • Ms. Jessica Hulsey Nickel, Founder, President, and CEO, Addiction Policy Forum
  • Mr. Ryan Hampton, Recovery Advocate, Facing Addiction
  • Ms. Carlene Deal-Smith, Peer Support Specialist, Presbyterian Medical Services
  • Dr. Mark Rosenberg, Chairman of Emergency Medicine and Chief Innovation Officer, St. Joseph's Healthcare System
  • Ms. Stacy Bohlen, CEO, National Indian Health Board
  • Ms. Alexis Horan, Vice President of Government Relations, Clean Slate Centers
RescheduledMar 21, 2018
HearingReauthorization of Animal Drug User Fees 2018: ADUFA and AGDUFARayburn House Office Building 2322
4 witnesses
  • Dr. Rachel Cumberbatch, Director, Regulatory Affairs, Animal Drugs, Animal Health Institute
  • Dr. Bill Zollers, Chairman, Generic Animal Drug Alliance
  • Dr. Michael Topper, American Veterinary Medical Association
  • Dr. Steven Solomon, Director, Center for Veterinary Medicine (CVM), Food and Drug Administration (FDA)
ScheduledMar 14, 2018
HearingMACRA and MIPS: An Update on the Merit-based Incentive Payment SystemRayburn House Office Building 2322CanceledMar 1, 2018
HearingCombating the Opioid Crisis: Helping Communities Balance Enforcement and Patient SafetyRayburn House Office Building 2123
10 witnesses
  • Ms. Susan Gibson, Deputy Assistant Attorney, Diversion Control Division, Drug Enforcement Administration
  • Dr. David Kan, President, California Society of Addiction Medicine
  • Mr. Richard Nance, Director, Utah County Department of Drug and Alcohol Prevention and Treatment
  • Mr. Thomas Cosgrove, Partner, Covington and Burling LLP
  • Dr. Andrew Kolodny, Co-Director, Opioid Policy Research, Brandeis University
  • Mr. Richard Logan, Owner, L&S Pharmacy
  • Dr. Ponni Subbiah, Chief Medical Officer, Indivior PLC
  • Mr. Frank Fowler, Chief of Police, Syracuse Police Department
  • Dr. Patrick Beardsley, Professor, Department of Pharmacology and Toxicology, Virginia Commonwealth University
  • Dr. John Mulder, Director, Trillium Institute
RescheduledFeb 28, 2018
HearingOversight of the Department of Health and Human ServicesRayburn House Office Building 2123
1 witness
  • The Honorable Alex Azar, Secretary, U.S. Department of Health and Human Services
ScheduledFeb 15, 2018
HearingExamining Implementation of the Compounding Quality ActRayburn House Office Building 2123
9 witnesses
  • The Honorable Scott Gottlieb,, Commissioner, Food and Drug Administration (FDA)
  • Ms. Nancy Dargan
  • Dr. Bruce Brod, Chair, Congressional Policy Committee, American Academy of Dermatology Association
  • Dr. George Williams, President Elect, American Academy of Ophthalmology
  • Mr. Shawn Hodges, Vice President, International Academy of Compounding Pharmacists
  • Ms. Jenn Adams, Senior Vice President and President, Clinical Product Solutions, PharMEDium Services
  • Ms. Molly Ventrelli, Vice President, Regulatory Affairs, Fresenius Kabi
  • Mr. Jacob Olson, President and CEO, Skywalk Pharmacy
  • Ms. Elizabeth Jungman, Director, Public Health, The Pew Charitable Trusts
ScheduledJan 30, 2018

By Congress

The committee's record in each Congress on file. Choose one to see the page as it stood then: its members, subcommittees and record. A dash means the official source has nothing that early, not that the committee did nothing.

CongressMembersBills referredReportedBecame lawMeetings
119th2025–2026, sitting323535225
118th2023–2024301,296901335
117th2021–2022341,379391327
116th2019–202049795371036
115th2017–201834780491750
114th2015–201631773281436
113th2013–201431741131825
112th2011–2012286511360
111th2009–2010397462710—
110th2007–2008338922720—
109th2005–200632815922—
108th2003–200481746522—
107th2001–2002337171112—

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress. Seats run from the 107th Congress, dated by the resolutions that made them and the Congressional Record; referrals and nominations from the 107th; meetings from the 112th. A committee older than that shows less than it has done. A subcommittee's referrals are recorded against it separately from its parent's, so the two lists do not add up. Records come from Congress.gov, GovInfo and the House and Senate.